Are concomitant treatments confounding factors in randomized controlled trials on intensive blood-glucose control in type 2 diabetes? a systematic review

BACKGROUND: Open-label, randomized controlled trials (RCTs) are subject to observer bias. If patient management is conducted without blinding, a difference between groups may be explained by other factors than study treatment. One factor may come from taking concomitant treatments with an efficacy o...

Descripción completa

Detalles Bibliográficos
Autores principales: Boussageon, Rémy, Supper, Irène, Erpeldinger, Sylvie, Cucherat, Michel, Bejan-Angoulvant, Theodora, Kassai, Behrouz, Cornu, Catherine, Gueyffier, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765855/
https://www.ncbi.nlm.nih.gov/pubmed/24229055
http://dx.doi.org/10.1186/1471-2288-13-107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765855/
https://www.ncbi.nlm.nih.gov/pubmed/24229055
http://dx.doi.org/10.1186/1471-2288-13-107

Ejemplares similares